Jinyong Peng

959 total citations
27 papers, 788 citations indexed

About

Jinyong Peng is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Jinyong Peng has authored 27 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Jinyong Peng's work include Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Jinyong Peng is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Jinyong Peng collaborates with scholars based in China. Jinyong Peng's co-authors include Lianhong Yin, Lina Xu, Youwei Xu, Yan Qi, Kexin Liu, Xu Han, Huijun Sun, Binan Lu, Xufeng Tao and Lingli Zheng and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Jinyong Peng

27 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinyong Peng China 17 381 167 116 97 84 27 788
Xiao-Dong Han China 9 557 1.5× 213 1.3× 85 0.7× 58 0.6× 70 0.8× 12 885
Lei Dong China 16 424 1.1× 141 0.8× 216 1.9× 87 0.9× 71 0.8× 42 1.0k
Jong-Hwan Kwak South Korea 13 271 0.7× 153 0.9× 83 0.7× 75 0.8× 118 1.4× 16 611
Lingli Zheng China 19 627 1.6× 221 1.3× 189 1.6× 93 1.0× 189 2.3× 38 1.2k
Binan Lu China 15 348 0.9× 208 1.2× 93 0.8× 42 0.4× 89 1.1× 32 768
Laila A. Eissa Egypt 22 399 1.0× 214 1.3× 236 2.0× 85 0.9× 81 1.0× 54 1.1k
Brian Chi‐Yan Cheng Hong Kong 18 521 1.4× 150 0.9× 95 0.8× 112 1.2× 127 1.5× 28 972
Ai‐Hsuan Lin Taiwan 16 497 1.3× 103 0.6× 87 0.8× 116 1.2× 83 1.0× 18 919
Xilan Tang China 13 260 0.7× 96 0.6× 167 1.4× 52 0.5× 91 1.1× 35 719

Countries citing papers authored by Jinyong Peng

Since Specialization
Citations

This map shows the geographic impact of Jinyong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyong Peng more than expected).

Fields of papers citing papers by Jinyong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyong Peng. The network helps show where Jinyong Peng may publish in the future.

Co-authorship network of co-authors of Jinyong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyong Peng. A scholar is included among the top collaborators of Jinyong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyong Peng. Jinyong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Meng, et al.. (2024). Protective effect of esculentoside A against myocardial infarction via targeting C-X-C motif chemokine receptor 2. Biomedicine & Pharmacotherapy. 174. 116529–116529. 3 indexed citations
2.
Yu, Hao, Ning Wang, Xuerong Zhao, Lan Han, & Jinyong Peng. (2024). Integrated serum pharmacochemistry with network pharmacology and pharmacological validation to elucidate the mechanism of yiqitongmai decoction (YQTMD) against myocardial infarction. Journal of Ethnopharmacology. 331. 118329–118329. 3 indexed citations
3.
Yin, Lianhong, Lili Li, Meng Gao, et al.. (2024). circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis. Redox Biology. 73. 103175–103175. 7 indexed citations
4.
Yin, Lianhong, et al.. (2023). Single-cell analysis of cellular heterogeneity and interactions in the ischemia-reperfusion injured mouse intestine. Journal of Pharmaceutical Analysis. 13(7). 760–775. 4 indexed citations
5.
Wang, Fei, Yilin Wang, Qiang Meng, et al.. (2022). MicroRNA-122a aggravates intestinal ischemia/reperfusion injury by promoting pyroptosis via targeting EGFR-NLRP3 signaling pathway. Life Sciences. 307. 120863–120863. 10 indexed citations
6.
Yin, Lianhong, et al.. (2021). 3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing. Acta Pharmaceutica Sinica B. 11(10). 3150–3164. 20 indexed citations
7.
8.
Xu, Lina, Lianhong Yin, Xufeng Tao, et al.. (2017). Dioscin, a potent ITGA5 inhibitor, reduces the synthesis of collagen against liver fibrosis: Insights from SILAC-based proteomics analysis. Food and Chemical Toxicology. 107(Pt A). 318–328. 27 indexed citations
9.
Liang, Jing, Changyuan Wang, Jinyong Peng, et al.. (2016). Naringin regulates cholesterol homeostasis and inhibits inflammation via modulating NF-κB and ERK signaling pathways in vitro.. PubMed. 71(2). 101–8. 16 indexed citations
10.
Wang, Changyuan, Qi Liu, Qiang Meng, et al.. (2015). Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis. European Journal of Pharmaceutical Sciences. 71. 73–79. 9 indexed citations
11.
Qi, Meng, Lingli Zheng, Yan Qi, et al.. (2015). Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70. Pharmacological Research. 100. 341–352. 78 indexed citations
12.
Yu, Hao, Lingli Zheng, Lianhong Yin, et al.. (2014). Protective effects of the total saponins from Dioscorea nipponica Makino against carbon tetrachloride-induced liver injury in mice through suppression of apoptosis and inflammation. International Immunopharmacology. 19(2). 233–244. 62 indexed citations
13.
Xu, Wei, Yang Lü, Jihong Yao, et al.. (2014). Novel Role of Resveratrol. Shock. 42(5). 440–447. 90 indexed citations
14.
Zhu, Liying, Lin Zhang, Libin Zhan, et al.. (2013). The effects of Zibu Piyin Recipe components on scopolamine-induced learning and memory impairment in the mouse. Journal of Ethnopharmacology. 151(1). 576–582. 28 indexed citations
15.
Han, Xu, Yan Qi, Lina Xu, et al.. (2013). Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway. Food and Chemical Toxicology. 59. 118–128. 75 indexed citations
16.
Zhang, Shuai, Lingli Zheng, Lina Xu, et al.. (2011). Subchronic toxicity study of the total flavonoids from Rosa laevigata Michx fruit in rats. Regulatory Toxicology and Pharmacology. 62(2). 221–230. 20 indexed citations
17.
18.
Sun, Changkai, Guozhu Han, Jinyong Peng, et al.. (2009). Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significanly correlated with cytochrome P450 suppression. World Journal of Gastroenterology. 15(15). 1829–1829. 47 indexed citations
19.
Xu, Youwei, et al.. (2007). [Preparative separation of gentiopicrin from Radix Gentianae by high-speed counter-current chromatography with macroporous resin].. PubMed. 32(24). 2595–7. 5 indexed citations
20.
Peng, Jinyong, Guorong Fan, & Yutian Wu. (2006). Two New Dihydroflavanoids from Patrinia villosa Juss (II). Chinese Chemical Letters. 17(4). 485–488. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao-Dong Han Breakdown of academic impact, for papers by Lei Dong Breakdown of academic impact, for papers by Jong-Hwan Kwak Breakdown of academic impact, for papers by Lingli Zheng Breakdown of academic impact, for papers by Binan Lu Breakdown of academic impact, for papers by Laila A. Eissa Breakdown of academic impact, for papers by Brian Chi‐Yan Cheng Breakdown of academic impact, for papers by Ai‐Hsuan Lin Breakdown of academic impact, for papers by Xilan Tang
Rankless by CCL
2026